Simponi
These highlights do not include all the information needed to use SIMPONI safely and effectively. See full prescribing information for SIMPONI. SIMPONI (golimumab) injection, for subcutaneous use Initial U.S. Approval: 2009
f86cb4a7-c358-4136-ae57-b32bda9bba00
HUMAN PRESCRIPTION DRUG LABEL
Nov 21, 2023
Janssen Biotech, Inc.
DUNS: 099091753
Products 2
Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.
golimumab
Product Details
FDA regulatory identification and product classification information
FDA Identifiers
Product Classification
Product Specifications
INGREDIENTS (6)
golimumab
Product Details
FDA regulatory identification and product classification information